Drug recall · October 29, 2025
Olopatadine Hydrochloride Ophthalmic Solution USP 0.1 % recall
Why: Failed Impurities/Degradation Specifications: The result for 'Any individual unspecified impurity' exceeds the specification limit.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Olopatadine Hydrochloride Ophthalmic Solution USP 0.1 %, 5 mL (0.17 FL OZ) bottles, Manufactured for: SOLA PHARMACEUTICALS LLC, Baton Rouge, LA 70810, NDC 70512-0520-05
- Lots / codes
Lot #: 35000409, Exp. Date 01/2026
- Quantity
- 8,952 bottles
- Company
- USV Private Limited, Dabhel, Daman
- Distribution
- Nationwide within the United States
- Initiated
- October 9, 2025 · Voluntary: Firm initiated
- Classified
- October 20, 2025
- Reported
- October 29, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Olopatadine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.